ISRCTN11560295已完成未知
Prognostic biomarkers in prostate cancer identified through bioinformatic analysis
Sichuan University0 个研究点目标入组 3,000 人开始时间: 2021年12月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 3,000
研究概览
简要总结
2022 Results article in https://pubmed.ncbi.nlm.nih.gov/36217461/ (added 06/01/2023) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35280985/ (added 06/01/2023) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/36109820/ (added 06/01/2023) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35463369/ (added 06/01/2023) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/36144737/ (added 06/01/2023) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35658892/ (added 06/01/2023) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35096608/ (added 06/01/2023)
研究设计
- 研究类型
- Observational
入排标准
- 性别
- Male
入选标准
- •Patients with prostate cancer in the TCGA and GEO databases
排除标准
- •Patients without prognostic information in the TCGA and GEO databases
研究者
相似试验
已完成
不适用
Identification of Predictive BiomarkersProstate Cancer RecurrentNCT04324983Martini-Klinik am UKE GmbH150
Unknown
不适用
Biomarkers in Prostate Cancer Treated With SRP Following Failure of FATProstatic NeoplasmsNCT03533998Institut Mutualiste Montsouris30
已完成
不适用
Prostate Cancer Upgrading Reference SetProstate CancerNCT02189486The University of Texas Health Science Center at San Antonio382
进行中（未招募）
不适用
Early vs. delayed screening for prostate cancerProstate cancerCancerISRCTN37591328German Cancer Aid46,000
已完成
不适用
Validation of the Stockholm3 Test for Detection of Prostate Cancer in the Swiss PopulationLocalized CarcinomaProstate CancerNCT05294627University Hospital, Basel, Switzerland380